Raymond Huggenberger - Jul 15, 2021 Form 4 Insider Report for Inogen Inc (INGN)

Role
Director
Signature
/s/ Alison Bauerlein, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
Jul 15, 2021
Transactions value $
-$306,662
Form type
4
Date filed
7/19/2021, 08:26 PM
Previous filing
Jun 17, 2021
Next filing
Aug 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Options Exercise $154K +4K +19.43% $38.54 24.6K Jul 15, 2021 Direct
transaction INGN Common Stock Sale -$449K -6.82K -27.75% $65.81 17.8K Jul 15, 2021 Direct F1, F2
transaction INGN Common Stock Sale -$11.9K -178 -1% $66.62 17.6K Jul 15, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Stock Option (Right to Buy) Options Exercise $0 -4K -16.8% $0.00 19.8K Jul 15, 2021 Common Stock 4K $38.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2 Represents the weighted average share price of an aggregate total of 6,822 shares sold in the price range of $65.258 to $66.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the share price of an aggregate total of 178 shares sold at a price of $66.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.